Jaume Sauleda

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease

Àlvar Agustí, Jaume Sauleda, Cristina Miralles et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 345 citations

Exercise Tolerance, Airflow Obstruction Present, Skeletal Muscle Apoptosis +13

Telomere shortening in smokers with and without COPD

Montse Morlá, Xavier Busquets, Jaime Pons et al. · European Respiratory Journal · 2006 · 326 citations · Full text

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

Judith García‐Aymerich, Félix Gómez, Marta Benet et al. · Thorax · 2010 · 316 citations · Full text

Molecular Analysis of the Contribution of the Capsular Polysaccharide and the Lipopolysaccharide O Side Chain to the Virulence of <i>Klebsiella pneumoniae</i> in a Murine Model of Pneumonia

Guadalupe Cortés, Núria Borrell, Beatriz de Astorza et al. · Infection and Immunity · 2002 · 312 citations · Full text